Skip to main content
. 2020 Jun 12;37(7):3392–3403. doi: 10.1007/s12325-020-01394-y

Fig. 2.

Fig. 2

Kaplan-Meier analysis of OS from start of 2L therapy in: a all patients (n = 86); b patients who received taxane-based (n = 37) and non-taxane-based (n = 49) 2L therapy. CI confidence interval, OS overall survival